Nichd Neonatal Research Network
Clinical trials sponsored by Nichd Neonatal Research Network, explained in plain language.
-
Preemie brain boost: drug may reduce transfusions and improve thinking skills
Disease control CompletedThis study tested a weekly injection of darbepoetin in 650 very premature infants (born at 23-28 weeks). The goal was to see if it could improve their thinking and learning abilities at age 2, compared to a placebo. The drug also aimed to reduce the number of blood transfusions t…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a common heart drug ease breathing in newborns with a rare birth defect?
Disease control CompletedThis study tested the drug milrinone in 66 newborns with congenital diaphragmatic hernia (CDH), a birth defect that causes severe breathing problems. The goal was to see if the drug could safely improve oxygen levels in the blood. The study compared milrinone to a placebo to chec…
Phase: PHASE2 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Blood transfusion study seeks best approach for tiniest babies
Knowledge-focused CompletedThis study looked at whether giving more blood transfusions to extremely low birth weight babies (under 2.2 pounds) helps them survive without brain or developmental problems. Over 1,800 infants were randomly assigned to receive transfusions at either higher or lower blood levels…
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Knowledge-focused
Last updated May 17, 2026 03:43 UTC